BIO-key International, Inc. (BKYI) stock forecast & analysis
3.12
NasdaqCM · USD
Up: +1.44, +85.7%
1 analysis
- Open
- 3.37
- Previous close
- 1.68
- Day range
- 2.70 – 4.66
- 52-week range
- 1.63 – 19.70
- Volume (shares)
- 168.69M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 1.44M
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- 0.40
- Market cap
- 4.48M
Market Scanner’s AI analysis of BIO-key International, Inc. (BKYI), updated September 2026: BKYI's Middle East expansion and FIDO certification contrasted with mixed technical indicators and a long-term downtrend.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of BIO-key International, Inc. (BKYI) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
BKYI's Middle East expansion and FIDO certification contrasted with mixed technical indicators and a long-term downtrend.
Recent analyses for BKYI covered a strategic expansion into the Middle East, including partnerships in the UAE and Saudi Arabia, alongside achieving FIDO Alliance full certification for its Passkey:YOU™ authentication. This news-driven growth is juxtaposed with mixed technical indicators, including a strong short-term price increase but a longer-term downtrend, with the current price below its 50-day and 200-day SMAs. Fundamental estimates project significant EPS and revenue growth for the next quarter, following recent positive EPS surprises.
BKYI news & sentiment
News sentiment for BKYI was positively influenced by strategic Middle East expansion and key technology certifications. Social media discussion was not covered in the provided notes.
BKYI technical picture
BKYI's price action showed strong recent upward momentum, though it remains below its 50-day and 200-day SMAs, indicating a longer-term downtrend. Momentum indicators suggest neutral to slightly bullish sentiment, with high buying pressure noted.
Fundamentals
The analysis covered forward EPS and revenue estimates, projecting significant growth for the next quarter. Recent performance showed positive EPS surprises, although one past quarter had a negative surprise. Valuation was touched on with a consensus price target based on one analyst's input.
Factors discussed — upside
- Strategic expansion into the Middle East with new partnerships.
- Achievement of FIDO Alliance full certification for Passkey:YOU™.
- Projected EPS growth of 76.4% for the next quarter.
- Projected revenue growth of 54.9% for the next quarter.
- Recent positive EPS surprises in Q2 and Q1 2026.
Factors discussed — risks
- Stock price below 50-day and 200-day SMAs.
- Longer-term downtrend indicated by a -30.8% change over 91 days.
- MACD is below zero, indicating bearish momentum.
- Market expansion
- Technological certification
- Fundamental growth projections
- Technical price trends
Summary updated .
BKYI technical indicators
Common technical indicators for BKYI, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 3.28 | Price below |
| 10-day exponential moving average | 2.39 | Price above |
| Relative strength index (14-day) | 57.22 | Neutral |
| MACD line (12/26/9) | -0.2774 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 1.85 – 3.28 | Price inside the bands |
Analyses
Recent BKYI.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for BIO-key International, Inc.?
- The bull case for BKYI centers on its strategic expansion into the Middle East, bolstered by new partnerships and the achievement of FIDO Alliance full certification for its authentication technology. Fundamental projections indicate significant growth in both earnings per share and revenue for the upcoming quarter, following a history of positive EPS surprises.
- What are the risks for BIO-key International, Inc.?
- Risks for BKYI include its current trading position below key long-term technical benchmarks, specifically the 50-day and 200-day SMAs, and a noted longer-term downtrend. Additionally, the MACD indicator suggests bearish momentum, contrasting with some short-term positive price action.
- Is BIO-key International, Inc. bullish or bearish?
- Recent AI analyses of BIO-key International, Inc. examined factors on both sides. Discussed upside: The bull case for BKYI centers on its strategic expansion into the Middle East, bolstered by new partnerships and the achievement of FIDO Alliance full certification for its authentication technology. Fundamental projections indicate significant growth in both earnings per share and revenue for the upcoming quarter, following a history of positive EPS surprises. Discussed risks: Risks for BKYI include its current trading position below key long-term technical benchmarks, specifically the 50-day and 200-day SMAs, and a noted longer-term downtrend. Additionally, the MACD indicator suggests bearish momentum, contrasting with some short-term positive price action. These are descriptive observations, not a recommendation.
- What is the latest sentiment on BIO-key International, Inc.?
- News sentiment for BKYI was positively influenced by strategic Middle East expansion and key technology certifications. Social media discussion was not covered in the provided notes.
- How does Market Scanner analyse BIO-key International, Inc.?
- Every analysis of BIO-key International, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
- Bundles used
- gemini-low-v2
Run a fresh BKYI.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.